Pictured: Jedd Wolchok
In the Clinic
Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Cancer Care; Clinical Trials; Immunotherapy; Treatment; Melanoma; Research
Add a Comment
Facebook Like
Pictured: Prasad Adusumilli
In the Lab
Study Reveals Immune Response as Potential Biomarker to Predict Recurrence of Lung Cancer
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, January 3, 2013

A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Immunotherapy; Immunology; Lung Cancer; Research
16 comments
Facebook Like
Pictured: Michel Sadelain
In the Lab
New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Cell Therapy; Immunotherapy; Immunology; Research
19 comments
Facebook Like
Pictured: Michel Sadelain & Jedd Wolchok
Announcement
Memorial Sloan-Kettering Researchers Appointed to Stand Up To Cancer Immunology “Dream Team”
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Immunotherapy; Immunology; Research
21 comments
Facebook Like
Pictured: Jedd Wolchok and James Allison
In the News
The New Yorker Features Immune Therapy Work of Memorial Sloan-Kettering Researchers
By Media Staff  |  Friday, April 20, 2012

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

Immunotherapy; Immunology; Research
Add a Comment
Facebook Like
Pictured: Jedd Wolchok
In the Clinic
Rare Medical Phenomenon: Melanoma Patient’s Tumors Disappear throughout the Body after Radiation of One Tumor
By Media Staff  |  Thursday, March 8, 2012

Findings from a multidisciplinary research team led by Memorial Sloan-Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Immunotherapy; Radiation Therapy; Immunology; Melanoma; Research
1 comment
Facebook Like
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Feature
Cell-Based Therapies Show Promise
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Cell Engineering; Cell Therapy; Immunotherapy; Drug Discovery; Experimental Therapeutics; Research
14 comments
Facebook Like
In the Lab
Researchers Show Therapy Could Improve Stem Cell Transplants
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 12, 2011

A Memorial Sloan-Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Blood & Marrow Stem Cell Transplantation; Immunotherapy; Drug Discovery; Immunology; Research
3 comments
Facebook Like

Featured Blog Posts

Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment
A Single Early PSA Test Found to Predict Long-Term Risk of Aggressive Prostate Cancer
Memorial Sloan-Kettering Experts Discuss Awake Surgery for Brain Tumors

Center News

Pictured: Center News, April 2013
Read Our Magazine »

Subscribe to Our E-newsletter

Get the latest information about cancer care.
Subscribe